850155P
18:1 PI(4,5)P2
Manufacturer: Sigma Aldrich
CAS Number: 799268-56-7
Synonym(S): 1,2-di-(9Z-octadecenoyl)-sn-glycero-3-[phosphoinositol-4,5-bisphosphate] (ammonium salt); PIP2[4′,5′](18:1(9Z)/18:1(9Z))
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| 100 μG | 850155P-100-μG | In Stock | ₹ 16,389.05 |
| 500 μG | 850155P-500-μG | In Stock | ₹ 59,429.25 |
850155P - 100 μG
In Stock
Quantity
1
Base Price: ₹ 16,389.05
GST (18%): ₹ 2,950.029
Total Price: ₹ 19,339.079
description
1,2-dioleoyl-sn-glycero-3-phospho-(1′-myo-inositol-4′,5′-bisphosphate) (ammonium salt)
Assay
>99% (TLC)
form
powder
packaging
pkg of 1 × 100 μg (with stopper and crimp cap (850155P-100ug))pkg of 1 × 500 μg (with stopper and crimp cap (850155P-500ug))
manufacturer/tradename
Avanti Polar Lipids
lipid type
phospholipidscardiolipins
shipped in
dry ice
storage temp.
−20°C
SMILES string
[H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](OP(O)([O-])=O)[C@H](OP([O-])(O)=O)[C@@H](O)[C@H]1O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[NH4+].[NH4+].[NH4+]
Related Products
Description
- General description: Although PI(4,5)P2 is a minor component of cell membranes, it plays a critical role as a substrate for a number of important signaling proteins. PI(4,5)P2 is an intermediate in the IP3/DAG pathway where it is hydrolyzed by phospholipase C to liberate the second messengers, inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). PI(4,5)P2 is also a substrate for PI 3-kinase where it is phosphorylated to PI(3,4,5)P3, an activator of downstream signaling components such as the protein kinase AKT.
- Application: 18:1 PI(4,5)P2 is suitable to use as a supplement in native macrophage membranes to generate phospholipid enriched membrane liposome.s[3] It has also been used:in the preparation of anionic phospholipid liposomes[4]as a component in supported membrane tube (SMrT) templates[5]in liposome preparation[6]
- Biochem/physiol Actions: Phosphatidylinositol bisphosphate (PIP2) can effectively stimulate the ATPase.[2]
- Packaging: 2 mL Amber Serum Vial with Stopper and Crimp Cap (850155P-100ug)
SAFETY INFORMATION
WGK
WGK 3
Compare Similar Items
Show Difference
description: 1,2-dioleoyl-sn-glycero-3-phospho-(1′-myo-inositol-4′,5′-bisphosphate) (ammonium salt)
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 100 μg (with stopper and crimp cap (850155P-100ug))pkg of 1 × 500 μg (with stopper and crimp cap (850155P-500ug))
manufacturer/tradename: Avanti Polar Lipids
lipid type: phospholipidscardiolipins
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](OP(O)([O-])=O)[C@H](OP([O-])(O)=O)[C@@H](O)[C@H]1O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[NH4+].[NH4+].[NH4+]
description:
1,2-dioleoyl-sn-glycero-3-phospho-(1′-myo-inositol-4′,5′-bisphosphate) (ammonium salt)
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 100 μg (with stopper and crimp cap (850155P-100ug))pkg of 1 × 500 μg (with stopper and crimp cap (850155P-500ug))
manufacturer/tradename:
Avanti Polar Lipids
lipid type:
phospholipidscardiolipins
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](OP(O)([O-])=O)[C@H](OP([O-])(O)=O)[C@@H](O)[C@H]1O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[NH4+].[NH4+].[NH4+]
description: __
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 100 μg (with stopper and crimp cap (850156P-100ug))pkg of 1 × 500 μg (with stopper and crimp cap (850156P-500ug))
manufacturer/tradename: Avanti Polar Lipids 850156P
lipid type: cardiolipinsphospholipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP(O[C@H]1[C@H](O)[C@@H](OP([O-])(O)=O)[C@H](OP(O)([O-])=O)[C@@H](OP(O)([O-])=O)[C@H]1O)([O-])=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[NH4+].[NH4+].[NH4+].[NH4+]
description:
__
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 100 μg (with stopper and crimp cap (850156P-100ug))pkg of 1 × 500 μg (with stopper and crimp cap (850156P-500ug))
manufacturer/tradename:
Avanti Polar Lipids 850156P
lipid type:
cardiolipinsphospholipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[H][C@@](COP(O[C@H]1[C@H](O)[C@@H](OP([O-])(O)=O)[C@H](OP(O)([O-])=O)[C@@H](OP(O)([O-])=O)[C@H]1O)([O-])=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCC/C=C\CCCCCCCC)=O.[NH4+].[NH4+].[NH4+].[NH4+]
description: __
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 1 mg (with stopper and crimp cap (850157P-1mg))pkg of 1 × 500 μg (with stopper and crimp cap (850157P-500ug))
manufacturer/tradename: Avanti Polar Lipids 850157P
lipid type: phospholipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](O)[C@H](OP([O-])(O)=O)[C@@H](O)[C@H]1O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O.[NH4+].[NH4+]
description:
__
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 1 mg (with stopper and crimp cap (850157P-1mg))pkg of 1 × 500 μg (with stopper and crimp cap (850157P-500ug))
manufacturer/tradename:
Avanti Polar Lipids 850157P
lipid type:
phospholipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](O)[C@H](OP([O-])(O)=O)[C@@H](O)[C@H]1O)=O)(OC(CCCCCCC/C=C\CCCCCCCC)=O)COC(CCCCCCCCCCCCCCC)=O.[NH4+].[NH4+]
description: __
Assay: >99% (TLC)
form: powder
packaging: pkg of 1 × 100 μg (with stopper and crimp cap (850164P-100ug))pkg of 1 × 500 μg (with stopper and crimp cap (850164P-500ug))
manufacturer/tradename: Avanti Polar Lipids 850164P
lipid type: cardiolipinsphospholipids
shipped in: dry ice
storage temp.: −20°C
SMILES string: [H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](OP(O)([O-])=O)[C@H](O)[C@@H](OP([O-])(O)=O)[C@H]1O)=O)(OC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O.[NH4+].[NH4+].[NH4+]
description:
__
Assay:
>99% (TLC)
form:
powder
packaging:
pkg of 1 × 100 μg (with stopper and crimp cap (850164P-100ug))pkg of 1 × 500 μg (with stopper and crimp cap (850164P-500ug))
manufacturer/tradename:
Avanti Polar Lipids 850164P
lipid type:
cardiolipinsphospholipids
shipped in:
dry ice
storage temp.:
−20°C
SMILES string:
[H][C@@](COP([O-])(O[C@H]1[C@H](O)[C@@H](OP(O)([O-])=O)[C@H](O)[C@@H](OP([O-])(O)=O)[C@H]1O)=O)(OC(CCC/C=C\C/C=C\C/C=C\C/C=C\CCCCC)=O)COC(CCCCCCCCCCCCCCCCC)=O.[NH4+].[NH4+].[NH4+]